Navigation Links
Transcept Pharmaceuticals to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
Date:4/28/2009

RICHMOND, Calif., April 28 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. announced today that Glenn A. Oclassen, President & Chief Executive Officer, is scheduled to present at the Bank of America and Merrill Lynch 2009 Health Care Conference in New York City on Tuesday, May 12, 2009 at 12:40 p.m., Eastern Time.

An audio webcast of the presentation will be available at www.transcept.com. The audio replay of the presentation will be available at the same location through May 26, 2009.

About Transcept Pharmaceuticals (TSPT)

Transcept Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. On January 30, 2009, Transcept completed a merger with Novacea, Inc. As part of the transaction, Novacea changed its name to "Transcept Pharmaceuticals, Inc." and its NASDAQ ticker symbol to "TSPT." The combined company resources resulting from the merger are expected to enable Transcept to successfully commercialize its lead product candidate, Intermezzo(R). If approved as anticipated, Intermezzo(R) will be the first commercially available sleep aid designed specifically for use in the middle of the night when patients awaken and have difficulty returning to sleep. Intermezzo(R) Phase 3 clinical trials have been completed and, on September 30, 2008, Transcept submitted a New Drug Application (NDA) for Intermezzo(R) to the U.S. Food and Drug Administration (FDA), which was accepted for filing on December 15, 2008. The FDA has assigned a PDUFA date of July 30, 2009 to the Intermezzo(R) NDA.

For further information, please visit the company's website at:

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Transcept Pharmaceuticals to Participate in Middle-of-the-Night (MOTN) Insomnia Investor Panel
2. Transcept Pharmaceuticals Appoints Key Senior Executives
3. Transcept Pharmaceuticals, Inc. to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference
4. Transcept Pharmaceuticals Announces FDA Acceptance for Review of New Drug Application for Intermezzo(R)
5. Transcept Pharmaceuticals to Present at 11th Annual BIO CEO & Investor Conference
6. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
7. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 2014 Lyfebulb, the International Pemphigus Pemphigoid ... NASDAQ OMX First North Premier, Stockholm ... a collaboration to increase awareness of unmet needs ... event attended by more than sixty patients, physicians, ... health and wellness company dedicated to serving the ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 International research ... announced that its biobanking project, Provia Laboratories , ... its growing Advisory Board. Scott Wolf , CEO ... have Dr. Vaught onboard with Provia’s ever-expanding Advisory Board. ... that Provia’s management team brings to this field, should ...
(Date:7/23/2014)... 2014  Sangamo BioSciences, Inc. (NASDAQ: SGMO ... and accomplishments. For the second quarter ... loss of $7.0 million, or $0.10 per share, compared ... per share, for the same period in 2013. As ... equivalents, marketable securities and interest receivable of $236.7 million. ...
(Date:7/23/2014)... Heroic worldwide conservation efforts have made great strides in ... in China, there are over 65 giant panda reserves ... But despite these efforts, just 1596 pandas remain in ... and zoos hope to save the panda by improving ... to the wild. Just how are these high-profile programs ...
Breaking Biology Technology:Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 2Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 3Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 4Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 5Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 2Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 3Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 4Sangamo BioSciences Reports Second Quarter 2014 Financial Results 2Sangamo BioSciences Reports Second Quarter 2014 Financial Results 3Sangamo BioSciences Reports Second Quarter 2014 Financial Results 4Sangamo BioSciences Reports Second Quarter 2014 Financial Results 5Sangamo BioSciences Reports Second Quarter 2014 Financial Results 6Sangamo BioSciences Reports Second Quarter 2014 Financial Results 7Sangamo BioSciences Reports Second Quarter 2014 Financial Results 8Sangamo BioSciences Reports Second Quarter 2014 Financial Results 9
... sales of $84.0 million, a 7% increase over last year,s first , ... year-over-year , - Record pre-tax income of $15.4 million , - ... , first quarter , - New products ... , - Improvements in gross margin continue to demonstrate the strong ...
... 4 SenesTech, Inc. scientists, Drs. Loretta Mayer, ... attend the Third International Workshop on Fertility Control ... they presented SenesTech,s latest developments in humane animal ... organized by the governments of Australia, the United ...
... Micell Technologies announced today that David E. Kandzari, ... DES System" during the Cardiovascular Research Technologies (CRT) ... MiStent(TM), a Drug-Eluting Stent (DES) in pre-clinical studies, ... potential benefits of the drug during the healing ...
Cached Biology Technology:Martek Announces First Quarter 2009 Financial Results 2Martek Announces First Quarter 2009 Financial Results 3Martek Announces First Quarter 2009 Financial Results 4Martek Announces First Quarter 2009 Financial Results 5Martek Announces First Quarter 2009 Financial Results 6Martek Announces First Quarter 2009 Financial Results 7Martek Announces First Quarter 2009 Financial Results 8Martek Announces First Quarter 2009 Financial Results 9Martek Announces First Quarter 2009 Financial Results 10SenesTech Scientists Attend International Workshop on Fertility in New Zealand 2Micell Technologies' Rapid Absorption Polymer DES System to be Presented at CRT 2009 2
(Date:7/23/2014)... 24, 2014 Pfenex Inc. (NYSE MKT: PFNX) today ... shares of its common stock at a price to the ... the underwriters a 30-day option to purchase up to 1,250,000 ... price. The shares are expected to begin trading on the ... William Blair & Company, L.L.C. and ...
(Date:7/23/2014)... identical twins has found that early reading skill might ... journal Child Development , was conducted by researchers ... , "Since reading is an ability that can be ... to Stuart J. Ritchie, research fellow in psychology at ... remediation of reading problems might aid not only the ...
(Date:7/23/2014)... neglected early in life are at risk for ... a new study, scientists have found that maltreatment ... implications for children,s long-term development. Previous studies focused ... genetics interacted with that child,s experiences in an ... the new study, researchers were able to measure ...
Breaking Biology News(10 mins):Pfenex Inc. Announces Pricing Of Initial Public Offering 2Stronger early reading skills predict higher intelligence later 2Stress tied to change in children's gene expression related to emotion regulation, physical health 2Stress tied to change in children's gene expression related to emotion regulation, physical health 3
... the standard biological model of animal cell communication, UCSF ... the ability to transmit and receive biological signals by ... distance. The mechanism is similar to the way ... understanding that non-neuronal cells "basically spit out signaling proteins ...
... not the only organ in your body that can sense cigarette ... Louis and the University of Iowa have showed that your lungs ... nose, which are located in the membranes of nerve cells, the ... Instead of sending nerve impulses to your brain that allow it ...
... early indication of lay opinions on research with induced ... from skin or other tissues, a new study by ... ethical concerns, patients give the research "broad endorsement". ... of participating in iPSC research even if personal benefit ...
Cached Biology News:Animal cells can communicate by reaching out and touching, UCSF team discovers 2Animal cells can communicate by reaching out and touching, UCSF team discovers 3Odor receptors discovered in lungs 2Odor receptors discovered in lungs 3Odor receptors discovered in lungs 4Study finds patients give 'broad endorsement' to stem cell research 2Study finds patients give 'broad endorsement' to stem cell research 3
Indoleamine 2,3-dioxygenase [IDO]...
E2F-5...
Mouse monoclonal [SH-A1] to S100 alpha ( Abpromise for all tested applications). entrezGeneID: 6271 SwissProtID: P23297...
Acid phosphatase (Potato). Monospecific by IEP. Some cross reactivity between Acid phosphatases of other species may occur....
Biology Products: